Biopharma
Two drugs, two strategies, one industry in the middle of rewiring its path to success
On May 20 Pfizer announced a US 6.05 billion licensing agreement with 3SBio a Chinese pharmaceutical company headquartered in the northeastern city of Shenyang for its in house developed...
1m